BioPharm International
January 01, 2013
Burrill on Biotech
26
1
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
January 01, 2013
Features
26
1
FDA talks about the changing scope of regulatory science.
January 01, 2013
Features
26
1
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
January 01, 2013
From the Editor
26
1
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
January 01, 2013
Regulatory Beat
26
1
Shortages spur efforts to overhaul manufacturing oversight.
January 01, 2013
European Beat
26
1
The EU fine-tunes the Falsified Medicines Directive.
January 01, 2013
Features
26
1
What the industry's future holds and what needs to be done to get there.
January 01, 2013
Global Reports
26
1
Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
January 01, 2013
Features
26
1
NIBRT's Ray O'Connor provides an overview of aseptic processing.
January 01, 2013
Features
26
1
Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.
January 01, 2013
Features
26
1
A new downstream purification platform using a salt-tolerant membrane adsorber.
January 01, 2013
Online Exclusive
26
1
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
January 01, 2013
Features
26
1
Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.
January 01, 2013
Perspectives on Outsourcing
26
1
Will international biomanufacturing outsourcing become mainstream in this decade?
January 01, 2013
Issue PDF
26
1
The Future of BioPharma Innovation